| 000 | 01402 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250512004053.0 | ||
| 264 | 0 | _c19900214 | |
| 008 | 199002s 0 0 fre d | ||
| 022 | _a0003-9683 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGueunoun, M | |
| 245 | 0 | 0 |
_a[Urokinase recanalization of extensive thrombosis of the superior vena cava secondary to an implantable perfusion device]. _h[electronic resource] |
| 260 |
_bArchives des maladies du coeur et des vaisseaux _cNov 1989 |
||
| 300 |
_a1913-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aCatheterization, Central Venous _xadverse effects |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHeparin _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfusion Pumps, Implantable _xadverse effects |
| 650 | 0 | 4 | _aJugular Veins |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPhlebography |
| 650 | 0 | 4 |
_aSuperior Vena Cava Syndrome _xdrug therapy |
| 650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xpharmacology |
| 650 | 0 | 4 |
_aVascular Patency _xdrug effects |
| 700 | 1 | _aEbagosti, A | |
| 700 | 1 | _aFavre, R | |
| 700 | 1 | _aTouboul-Gueunoun, E | |
| 700 | 1 | _aLevy, S | |
| 773 | 0 |
_tArchives des maladies du coeur et des vaisseaux _gvol. 82 _gno. 11 _gp. 1913-6 |
|
| 999 |
_c2520641 _d2520641 |
||